Literature DB >> 32273473

Erythrocytapheresis as a novel treatment option for adult patients with pyruvate kinase deficiency.

Rawia F G Jensen1, Morten H Dziegiel2,3, Klaus Rieneck2, Henrik Birgens1, Andreas Glenthøj4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32273473      PMCID： PMC7327632          DOI： 10.3324/haematol.2020.246686

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  Pyruvate kinase (PK) deficiency hereditary nonspherocytic hemolytic anemia.

Authors:  K R TANAKA; W N VALENTINE; S MIWA
Journal:  Blood       Date:  1962-03       Impact factor: 22.113

Review 2.  Consequences and management of iron overload in sickle cell disease.

Authors:  John Porter; Maciej Garbowski
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 3.  How we manage patients with pyruvate kinase deficiency.

Authors:  Rachael F Grace; D Mark Layton; Wilma Barcellini
Journal:  Br J Haematol       Date:  2019-01-25       Impact factor: 6.998

4.  Phenobarbitone of jaundice in haemolytic patients.

Authors:  G Perona; R Corrocher; M Frezza; G C Falezza; R Cellerino; C Tiribelli; A Fusaro; G De Sandre
Journal:  Br J Haematol       Date:  1973-12       Impact factor: 6.998

Review 5.  Red cell pyruvate kinase deficiency: molecular and clinical aspects.

Authors:  Alberto Zanella; Elisa Fermo; Paola Bianchi; Giovanna Valentini
Journal:  Br J Haematol       Date:  2005-07       Impact factor: 6.998

Review 6.  Selecting red blood cell units to perform RBCX in patients with sickle cell disease.

Authors:  M Raba
Journal:  Transfus Apher Sci       Date:  2019-03-13       Impact factor: 1.764

7.  Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study.

Authors:  Rachael F Grace; Paola Bianchi; Eduard J van Beers; Stefan W Eber; Bertil Glader; Hassan M Yaish; Jenny M Despotovic; Jennifer A Rothman; Mukta Sharma; Melissa M McNaull; Elisa Fermo; Kimberly Lezon-Geyda; D Holmes Morton; Ellis J Neufeld; Satheesh Chonat; Nina Kollmar; Christine M Knoll; Kevin Kuo; Janet L Kwiatkowski; Dagmar Pospíšilová; Yves D Pastore; Alexis A Thompson; Peter E Newburger; Yaddanapudi Ravindranath; Winfred C Wang; Marcin W Wlodarski; Heng Wang; Susanne Holzhauer; Vicky R Breakey; Joachim Kunz; Sujit Sheth; Melissa J Rose; Heather A Bradeen; Nolan Neu; Dongjing Guo; Hasan Al-Sayegh; Wendy B London; Patrick G Gallagher; Alberto Zanella; Wilma Barcellini
Journal:  Blood       Date:  2018-03-16       Impact factor: 22.113

8.  Selective reticulocyte destruction in erythrocyte pyruvate kinase deficiency.

Authors:  W C Mentzer; R L Baehner; H Schmidt-Schönbein; S H Robinson; D G Nathan
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

9.  Bilirubin turnover studies in normal and pathologic states using bilirubin-14C.

Authors:  V Barrett; P D Berk; M Menken; N I Berlin
Journal:  Ann Intern Med       Date:  1968-02       Impact factor: 25.391

Review 10.  Erythrocyte pyruvate kinase deficiency: 2015 status report.

Authors:  Rachael F Grace; Alberto Zanella; Ellis J Neufeld; D Holmes Morton; Stefan Eber; Hassan Yaish; Bertil Glader
Journal:  Am J Hematol       Date:  2015-08-14       Impact factor: 10.047
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.